Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
ACS Nano|July 5, 2024
Quantitative Visualization of Lipid Nanoparticle Fusion as a Function of Formulation and Process ParametersAlbert Kamanzi, Yao Zhang, Yifei Gu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 16, 2012
Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNAPaulo J C Lin, Yuen Yi C Tam, Ismail Hafez, et al.
Journal of Medicinal Chemistry|May 19, 2015
Pyrimethamine Derivatives: Insight into Binding Mechanism and Improved Enhancement of Mutant β-N-acetylhexosaminidase ActivityMichael B Tropak, Jianmin Zhang, Sayuri Yonekawa, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 11, 2012
Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNAYuen Yi C Tam, Sam Chen, Josh Zaifman, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target Clostridioides difficileDahyun Kim, Young-Rok Kim, Hee-Jong Hwang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2010
Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticlesIgor V Zhigaltsev, Geoff Winters, Masuna Srinivasulu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 2, 2021
Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug DeliveryRoy van der Meel, Sam Chen, Josh Zaifman, et al.
International Journal of Cancer|November 19, 2011
Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivoJustin B Lee, Kaixin Zhang, Yuen Yi C Tam, et al.
Blood|August 27, 2024
Genetic engineering of transfusable platelets with mRNA-lipid nanoparticles is compatible with blood banking practicesColton Strong, Jerry Leung, Emma Kang, et al.
Vascular Pharmacology|September 30, 2022
Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive propertiesElodie Sauge, Dmitri Pechkovsky, N D Prasad Atmuri, et al.
Pageof 7